Roivant Sciences Ltd. ROIV
40.67 USD +1.79 (+4.60%)
At closeNov 9, 2026, 4:56 PM EST
40.55 -0.12 -0.30%
After hours · Nov 9, 4:56 PM ET
39.22 Day range 41.43
20.10 52-week range 41.81
- YTD
- +87.42%
- 1 year
- +97.24%
Revenue & Expenses
Latest period ending Mar 31, 2026 · select a line to chart its full history
Income statement
| Fiscal year | FY 2026 Mar 31, 2026 | FY 2025 Mar 31, 2025 | FY 2024 Mar 31, 2024 | FY 2023 Mar 31, 2023 | FY 2022 Mar 31, 2022 |
|---|---|---|---|---|---|
| 8.26M | 29.05M | 32.71M | 31.53M | 55.29M | |
| 6.97M | 28.14M | 31.11M | 28.50M | 46.32M | |
| -515.07M | -1.00B | 4.50B | -906.76M | -1.35B | |
| -299.77M | -171.98M | 4.35B | -1.01B | -845.26M | |
| -0.54 | -0.24 | 5.23 | -1.42 | -1.26 |
Balance sheet
| Fiscal year | FY 2026 Mar 31, 2026 | FY 2025 Mar 31, 2025 | FY 2024 Mar 31, 2024 | FY 2023 Mar 31, 2023 | FY 2022 Mar 31, 2022 |
|---|---|---|---|---|---|
| 1.42B | 2.72B | 6.49B | 1.68B | 2.06B | |
| 5.71B | 5.44B | 7.22B | 2.39B | 2.59B | |
| 416.27M | 249.74M | 773.95M | 782.02M | 523.70M | |
| 107.44M | 100.17M | 53.99M | 481.40M | 283.89M | |
| 4.53B | 4.69B | 5.97B | 1.16B | 1.66B |
Cash flow
| Fiscal year | FY 2026 Mar 31, 2026 | FY 2025 Mar 31, 2025 | FY 2024 Mar 31, 2024 | FY 2023 Mar 31, 2023 | FY 2022 Mar 31, 2022 |
|---|---|---|---|---|---|
| -750.35M | -839.45M | -765.27M | -843.39M | -677.73M | |
| -682.33M | -1.77B | 5.20B | -44.27M | 303.30M | |
| 134.24M | -1.22B | 419.36M | 499.46M | 306.79M | |
| -8.21M | -4.60M | -1.38M | -12.69M | -17.44M | |
| -1.29B | -3.82B | 4.86B | -381.92M | -67.64M |